Literature DB >> 14304054

CIRCULATING ANTIBODIES TO DIETARY PROTEINS IN ULCERATIVE COLITIS.

R WRIGHT, S C TRUELOVE.   

Abstract

Keywords:  ALBUMINS; ANTIBODIES; BLOOD; CASEIN; COLITIS, ULCERATIVE; DIETARY PROTEINS; FOOD HYPERSENSITIVITY; GLOBULINS; GLUTEN; HEMAGGLUTINATION; LACTOGLOBULINS; MILK; OVALBUMIN; STATISTICS

Mesh:

Substances:

Year:  1965        PMID: 14304054      PMCID: PMC1845711          DOI: 10.1136/bmj.2.5454.142

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


× No keyword cloud information.
  9 in total

1.  SMALL-INTESTINAL AND GASTRIC CHANGES IN ULCERATIVE COLITIS: A BIOPSY STUDY.

Authors:  S N SALEM; S C TRUELOVE; W C RICHARDS
Journal:  Br Med J       Date:  1964-02-15

2.  Circulating antibodies to cow's milk proteins and gluten in the newborn.

Authors:  R WRIGHT; K B TAYLOR; S C TRUELOVE
Journal:  Br Med J       Date:  1962-08-25

3.  An immunological study of coeliac disease and idiopathic steatorrhoea. Serological reactions to gluten and milk proteins.

Authors:  K B TAYLOR; S C TRUELOVE; D L THOMSON; R WRIGHT
Journal:  Br Med J       Date:  1961-12-30

4.  Immune responses in infants to cow's milk proteins taken by mouth.

Authors:  M GUNTHER; E CHEEK; R H MATTHEWS; R R COOMBS
Journal:  Int Arch Allergy Appl Immunol       Date:  1962

5.  Circulating antibodies to milk proteins in ulcerative colitis.

Authors:  K B TAYLOR; S C TRUELOVE
Journal:  Br Med J       Date:  1961-10-07

6.  Gluten-induced enteropathy: the effect of partially digested gluten.

Authors:  A C FRAZER; R F FLETCHER; C A ROSS; B SHAW; H G SAMMONS; R SCHNEIDER
Journal:  Lancet       Date:  1959-09-05       Impact factor: 79.321

7.  The level of antibodies to the proteins of cow's milk in the serum of normal human infants.

Authors:  M GUNTHER; R ASCHAFFENBURG; R H MATTHEWS; W E PARISH; R R COOMBS
Journal:  Immunology       Date:  1960-10       Impact factor: 7.397

8.  MILK ALLERGY. III. IMMUNOLOGICAL STUDIES WITH SERA FROM ALLERGIC AND NORMAL CHILDREN.

Authors:  S SAPERSTEIN; D W ANDERSON; A S GOLDMAN; W T KNIKER
Journal:  Pediatrics       Date:  1963-10       Impact factor: 7.124

9.  The adsorption of proteins on erythrocytes treated with tannic acid and subsequent hemagglutination by antiprotein sera.

Authors:  S V BOYDEN
Journal:  J Exp Med       Date:  1951-02       Impact factor: 14.307

  9 in total
  16 in total

1.  A CONTROLLED THERAPEUTIC TRIAL OF VARIOUS DIETS IN ULCERATIVE COLITIS.

Authors:  R WRIGHT; S C TRUELOVE
Journal:  Br Med J       Date:  1965-07-17

Review 2.  The medical treatment of ulcerative colitis.

Authors:  G Watkinson
Journal:  Postgrad Med J       Date:  1968-09       Impact factor: 2.401

3.  Ulcerative colitis: definition, historical background, aetiology, diagnosis, naturel history and local complications.

Authors:  F T De Dombal
Journal:  Postgrad Med J       Date:  1968-09       Impact factor: 2.401

4.  Ulcerative colitis: an overview.

Authors:  A Archambault
Journal:  Can Fam Physician       Date:  1990-02       Impact factor: 3.275

Review 5.  Idiopathic Inflammation Bowel Disease: is there a role for immunological mechanisms in etiopathogenesis?

Authors:  R G Shorter
Journal:  Gastroenterol Jpn       Date:  1982-10

6.  Anti-albumin antibodies in sera of patients with gastro-intestinal disease.

Authors:  N Tamura
Journal:  Gastroenterol Jpn       Date:  1982

7.  Serial rectal biopsy in ulcerative colitis during the course of a controlled therapeutic trial of various diets.

Authors:  R Wright; S R Truelove
Journal:  Am J Dig Dis       Date:  1966-11

8.  Circulating and tissue eosinophils in ulcerative colitis.

Authors:  R Wright; S C Truelove
Journal:  Am J Dig Dis       Date:  1966-11

9.  Disodium cromoglycate in the treatment of chronic proctitis.

Authors:  R V Heatley; B J Calcraft; J Rhodes; E Owen; B K Evans
Journal:  Gut       Date:  1975-07       Impact factor: 23.059

10.  Is the diarrhoea in ulcerative colitis related to impaired colonic salvage of carbohydrate?

Authors:  S S Rao; N W Read; C D Holdsworth
Journal:  Gut       Date:  1987-09       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.